Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Papulosquamous

Explore clinical trials studying Skin Diseases, Papulosquamous. Study availability and eligibility vary by location and protocol.

1,740 public trials 205 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Papulosquamous trial results

Completed

A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis

NCT01585233

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Specialist Connect Brisbane, Queensland, Australia
  • CMAX Adelaide, Victoria, Australia
  • Epworth Hospital Richmond, Victoria, Australia
  • Linear Research Nedlands, Western Australia, Australia
View all 13 locations
View Trial Details
Completed

A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

NCT06073119

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Scottsdale Clinical Trials Site Number : 8400025 Scottsdale, Arizona, United States
  • Dermatology Research Associates- Site Number : 8400019 Los Angeles, California, United States
  • Daxia Trials Site Number : 8400022 Boca Raton, Florida, United States
  • Renaissance Research and Medical Group, Inc- Site Number : 8400018 Cape Coral, Florida, United States
View all 51 locations
View Trial Details
Completed

Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

NCT05478499

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Local Institution - 0001 Hot Springs, Arkansas, United States
  • Local Institution - 0007 Indianapolis, Indiana, United States
  • Local Institution - 0041 Louisville, Kentucky, United States
  • Local Institution - 0022 Rockville, Maryland, United States
View all 29 locations
View Trial Details
Completed

An Expanded Access Program in China to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options

NCT05239039

Conditions
Generalized Pustular Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Beijing Friendship Hospital Beijing, China
  • West China Hospital Chengdu, China
  • Southern Medical University Dermatology Hospital Guangzhou, China
  • The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou, China
View Trial Details
Completed

A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis

NCT04399837

Conditions
Generalized Pustular Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Oakland Hills Dermatology Auburn Hills, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Buenos Aires Skin S.A. CABA, Argentina
  • Hospital Italiano de Buenos Aires CABA, Argentina
View all 72 locations
View Trial Details
Completed

A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

NCT04015518

Conditions
Palmoplantar Pustulosis (PPP), Psoriasis, Skin Diseases, +2 more
Locations
  • Total Skin and Beauty Dermatology Center, PC Birmingham, Alabama, United States
  • Wallace Medical Group Beverly Hills, California, United States
  • Therapeutics Clinical Research San Diego, California, United States
  • Advanced Medical Research PC Sandy Springs, Georgia, United States
View all 88 locations
View Trial Details
Completed

Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

NCT03782792

Conditions
Generalized Pustular Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Miami Miami, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View all 37 locations
View Trial Details
Completed

Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment

NCT04632927

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations
  • Novartis Investigative Site Rendsburg, Schleswig-Holstein, Germany
  • Novartis Investigative Site Aachen, Germany
  • Novartis Investigative Site Bad Bentheim, Germany
  • Novartis Investigative Site Bad Doberan, Germany
View all 28 locations
View Trial Details

Related conditions